Lab, Molecular Technologist (GI)(PIT) Schedule: 5:00 am - 1:30 pm
Castle Biosciences, Inc.
Pittsburgh, PA
Health / Beauty / Fitness
Learn more: www.CastleBiosciences.com
Castle Biosciences Inc. is growing, and we are looking to hire Molecular Technologists working from our laboratory in Pittsburgh, PA @ Nova Place location, with a start date of July 1, 2026.
Why Castle Biosciences?
Exceptional Benefits Package
- Excellent Annual Salary + 20% Bonus Potential
- 20 Accrued PTO Days Annually
- 10 Paid Holidays
- 401K with 100% Company Match up to 6%
- 3 Health Care Plan Options + Company HSA Contribution
- Company Stock Grant Upon Hire
A typical day for the Molecular Technologist includes sample multiplexed immunofluorescent labeling/staining, digital imaging, quality control review of digital imaging, and test analysis output reviews. The technologist would be working with equipment setups for staining and imaging, as well as reagent preparations, specimen management, and assisting with inventory and quality management tasks as needed. This role will spend the most time on three main activities: histological staining and imaging, specimen management and preparation, and quality control review checks and documentation associated with high complexity clinical laboratory testing.
Requirements
- Bachelor of Science Degree in Chemistry, Biology, Clinical Laboratory Science, or Medical Technology from an accredited institution, plus 1-2 years of experience in a molecular biology testing environment, clinical, or equivalent laboratory environment. And/or have completion of military training for laboratory technicians as high complexity testing personnel. Completion of a 50-week U.S. military medical laboratory training program
- Minimum coursework and training requirements:
- 24 semester hours of medical laboratory technology courses or 24 semester hours of science courses, including 6 semester hours of both Chemistry & Biology & an additional 12 semester hours in any combination of Chemistry, Biology, or Medical Laboratory Science.
- AND Completion of a clinical laboratory training program, OR at least 3 months of documented laboratory training in each specialty area where the individual will perform high-complexity testing.
- The Molecular Technologists in the clinical laboratory are placed on a track towards obtaining American Society of Clinical Pathology (ASCP) Technologist in Molecular Biology (MB) board certification if not already credentialed upon hire and expected to obtain such a certification within 2 years of employment. (Only applicable to PHX)
- Monday-Friday, from 5:00 AM to 1:30 PM, exempt position, working from the Pittsburgh, PA @ Nova Place laboratory location.
We truly appreciate your time. If this feels like the right opportunity for you, we'd love for you to complete our mobile-friendly application. We're excited to learn more about you and look forward to connecting soon!
Castle Biosciences Awards and Research Developments!
WORK AUTHORIZATION
All candidates must be legally authorized to work in the United States. Currently, Castle Biosciences does not sponsor H-1B visas, OPT, or employment-related visas.
About Castle Biosciences Inc.
At Castle, it all comes down to people. After all, disease doesn't just happen - it happens to people. We believe that disease management and treatment decisions can be better informed through a person's unique biology, which is revealed through the scientific rigor of our innovative, laboratory-developed tests. We are committed to empowering healthcare providers and patients with the goal of improved outcomes.
Every employee at Castle has an impact on patient care, and we work to ensure that everyone finds their work to be both challenging and rewarding. We behave with integrity and treat our colleagues with respect and kindness. Our culture fosters an environment of trust, transparency, and collaboration. We prioritize and encourage internal growth and professional development.
Castle Biosciences is an equal opportunity employer as to all protected groups, including protected veterans and individuals with disabilities.
If you have a disability and you believe you need a reasonable accommodation in order to search for a job opening or to submit an online application, please e-mail [email protected].
This email was created exclusively to assist disabled job seekers whose disability prevents them from being able to apply online. Only messages left for this purpose will be returned. Messages left for other purposes, such as following up on an application or technical issues not related to a disability, will not receive a response.
- No third-party recruiters, please
About the company
Company website•Biotechnology Research
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
The Company’s innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. Castle currently markets five proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, Barrett’s esophagus, and uveal melanoma.
DecisionDx®-Melanoma, Castle’s test for invasive cutaneous melanoma, is a proprietary gene expression profile (GEP) test that uses an individual patient’s tumor biology to predict the risk of metastasis or recurrence, as well as the risk of sentinel lymph node positivity, independent of traditional staging factors.
DecisionDx®-SCC is the Company’s GEP test that predicts the risk of metastasis in patients with cutaneous squamous cell carcinoma, who have one or more risk factors.
MyPath® Melanoma provides a highly accurate, objective result to aid dermatopathologists and dermatologists in characterizing suspicious pigmented lesions.
TissueCypher® Barrett’s Esophagus is the world’s first precision medicine test designed to predict future development of esophageal cancer in patients with Barrett’s esophagus.
DecisionDx®-UM, the standard of care in uveal melanoma staging, is Castle's GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer.
Castle Biosciences is based in Friendswood, TX, (a suburb of Houston) and has laboratory operations in Phoenix, AZ, and Pittsburgh, PA.